Page 61 - Roche Diagnostics News Today

SCIENTISTS have marked two years since launching the world’s first commercially available PCR test for Covid-19.

/PRNewswire/ -- Based on its recent analysis of the Indian in vitro diagnostics (IVD) market, Frost & Sullivan recognizes Roche Diagnostics India with the 2021...

Increasing Demand for Coagulation Testing at Physician’s Office Are the Factors That Are Set To Drive the Growth of the Primary Care POC Diagnostics Market

In this article, Roche demonstrates how their KAPA HyperPETE workflow can provide improved targeted next-generation sequencing (NGS), and thereby provide strong therapeutic prospects for cancerresearch.

/PRNewswire/ -- Based on its recent analysis of the Indian in vitro diagnostics (IVD) market, Frost & Sullivan recognizes Roche Diagnostics India with the 2021...

The Factors Such As Growing Aging Population and Increasing Usage of Point-of-Care Testing and Personalized Medicine Are Among the Major Factor Projected To Impel Growth of Cancer IVD Market.

Its technology-centric solutions enable hospitals to enhance operational efficiency and enable faster clinical decision making MUMBAI, India, March 14, 2022 /PRNewswire/ -- Based on its recent analysis of the Indian in vitro diagnostics (IVD) market, Frost & Sullivan recognizes Roche Diagnostics India with the 2021 India Competitive Strategy Leadership Award for its well-executed country strategies, effective market penetration, and...

Key Players Covered in Lung Cancer Diagnostics Market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, AstraZeneca plc, Illumina Inc., Agilent...

Prenosis, Inc., a precision medicine company, announced a venture investment from PACE Healthcare Capital, an early-stage investment firm committed to improving health outcomes.

Read about news from Equiva, Healthmine, Prenosis, 9am.health, and Socially Determined.